G2019s-LRRK2 expression augments α-synuclein sequestration into inclusions in neurons

Laura A. Volpicelli-Daley, Hisham Abdelmotilib, Zhiyong Liu, Lindsay Stoyka, João Paulo Lima Daher, Austen J. Milnerwood, Vivek Unni, Warren D. Hirst, Zhenyu Yue, Hien T. Zhao, Kyle Fraser, Richard E. Kennedy, Andrew B. West

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Pathologic inclusions define α-synucleinopathies that include Parkinson’s disease (PD). The most common genetic cause of PD is the G2019S LRRK2 mutation that upregulates LRRK2 kinase activity. However, the interaction between α -synuclein, LRRK2, and the formation of α -synuclein inclusions remains unclear. Here, we show that G2019S-LRRK2 expression, in both cultured neurons and dopaminergic neurons in the rat substantia nigra pars compact, increases the recruitment of endogenous α -synuclein into inclusions in response to α -synuclein fibril exposure. This results from the expression of mutant G2019S-LRRK2, as overexpression ofWT-LRRK2not only does not increase formation of inclusions but reduces their abundance. In addition, treatment of primary mouse neurons with LRRK2 kinase inhibitors, PF-06447475 and MLi-2, blocks G2019S-LRRK2 effects, suggesting that the G2019S-LRRK2 potentiation of inclusion formation depends on its kinase activity. Overexpression of G2019S-LRRK2 slightly increases, whereas WT-LRRK2 decreases, total levels of α -synuclein. Knockdown of total α -synuclein with potent antisense oligonucleotides substantially reduces inclusion formation in G2019S-LRRK2-expressing neurons, suggesting that LRRK2 influences α -synuclein inclusion formation by altering α -synuclein levels. These findings support the hypothesis that G2019S-LRRK2 may increase the progression of pathological α -synuclein inclusions after the initial formation of α -synuclein pathology by increasing a pool of α -synuclein that is more susceptible to forming inclusions.

Original languageEnglish (US)
Pages (from-to)7415-7427
Number of pages13
JournalJournal of Neuroscience
Volume36
Issue number28
DOIs
StatePublished - Jul 13 2016

Fingerprint

Synucleins
Neurons
Phosphotransferases
Parkinson Disease
Antisense Oligonucleotides
Dopaminergic Neurons
Substantia Nigra

Keywords

  • Lewy body
  • Lewy neurite
  • LRRK2
  • Parkinson’s
  • Synuclein

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Volpicelli-Daley, L. A., Abdelmotilib, H., Liu, Z., Stoyka, L., Daher, J. P. L., Milnerwood, A. J., ... West, A. B. (2016). G2019s-LRRK2 expression augments α-synuclein sequestration into inclusions in neurons. Journal of Neuroscience, 36(28), 7415-7427. https://doi.org/10.1523/JNEUROSCI.3642-15.2016

G2019s-LRRK2 expression augments α-synuclein sequestration into inclusions in neurons. / Volpicelli-Daley, Laura A.; Abdelmotilib, Hisham; Liu, Zhiyong; Stoyka, Lindsay; Daher, João Paulo Lima; Milnerwood, Austen J.; Unni, Vivek; Hirst, Warren D.; Yue, Zhenyu; Zhao, Hien T.; Fraser, Kyle; Kennedy, Richard E.; West, Andrew B.

In: Journal of Neuroscience, Vol. 36, No. 28, 13.07.2016, p. 7415-7427.

Research output: Contribution to journalArticle

Volpicelli-Daley, LA, Abdelmotilib, H, Liu, Z, Stoyka, L, Daher, JPL, Milnerwood, AJ, Unni, V, Hirst, WD, Yue, Z, Zhao, HT, Fraser, K, Kennedy, RE & West, AB 2016, 'G2019s-LRRK2 expression augments α-synuclein sequestration into inclusions in neurons' Journal of Neuroscience, vol. 36, no. 28, pp. 7415-7427. https://doi.org/10.1523/JNEUROSCI.3642-15.2016
Volpicelli-Daley LA, Abdelmotilib H, Liu Z, Stoyka L, Daher JPL, Milnerwood AJ et al. G2019s-LRRK2 expression augments α-synuclein sequestration into inclusions in neurons. Journal of Neuroscience. 2016 Jul 13;36(28):7415-7427. https://doi.org/10.1523/JNEUROSCI.3642-15.2016
Volpicelli-Daley, Laura A. ; Abdelmotilib, Hisham ; Liu, Zhiyong ; Stoyka, Lindsay ; Daher, João Paulo Lima ; Milnerwood, Austen J. ; Unni, Vivek ; Hirst, Warren D. ; Yue, Zhenyu ; Zhao, Hien T. ; Fraser, Kyle ; Kennedy, Richard E. ; West, Andrew B. / G2019s-LRRK2 expression augments α-synuclein sequestration into inclusions in neurons. In: Journal of Neuroscience. 2016 ; Vol. 36, No. 28. pp. 7415-7427.
@article{ef3a4d2ee15f4333b3fc0da0293a6dbc,
title = "G2019s-LRRK2 expression augments α-synuclein sequestration into inclusions in neurons",
abstract = "Pathologic inclusions define α-synucleinopathies that include Parkinson’s disease (PD). The most common genetic cause of PD is the G2019S LRRK2 mutation that upregulates LRRK2 kinase activity. However, the interaction between α -synuclein, LRRK2, and the formation of α -synuclein inclusions remains unclear. Here, we show that G2019S-LRRK2 expression, in both cultured neurons and dopaminergic neurons in the rat substantia nigra pars compact, increases the recruitment of endogenous α -synuclein into inclusions in response to α -synuclein fibril exposure. This results from the expression of mutant G2019S-LRRK2, as overexpression ofWT-LRRK2not only does not increase formation of inclusions but reduces their abundance. In addition, treatment of primary mouse neurons with LRRK2 kinase inhibitors, PF-06447475 and MLi-2, blocks G2019S-LRRK2 effects, suggesting that the G2019S-LRRK2 potentiation of inclusion formation depends on its kinase activity. Overexpression of G2019S-LRRK2 slightly increases, whereas WT-LRRK2 decreases, total levels of α -synuclein. Knockdown of total α -synuclein with potent antisense oligonucleotides substantially reduces inclusion formation in G2019S-LRRK2-expressing neurons, suggesting that LRRK2 influences α -synuclein inclusion formation by altering α -synuclein levels. These findings support the hypothesis that G2019S-LRRK2 may increase the progression of pathological α -synuclein inclusions after the initial formation of α -synuclein pathology by increasing a pool of α -synuclein that is more susceptible to forming inclusions.",
keywords = "Lewy body, Lewy neurite, LRRK2, Parkinson’s, Synuclein",
author = "Volpicelli-Daley, {Laura A.} and Hisham Abdelmotilib and Zhiyong Liu and Lindsay Stoyka and Daher, {Jo{\~a}o Paulo Lima} and Milnerwood, {Austen J.} and Vivek Unni and Hirst, {Warren D.} and Zhenyu Yue and Zhao, {Hien T.} and Kyle Fraser and Kennedy, {Richard E.} and West, {Andrew B.}",
year = "2016",
month = "7",
day = "13",
doi = "10.1523/JNEUROSCI.3642-15.2016",
language = "English (US)",
volume = "36",
pages = "7415--7427",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "28",

}

TY - JOUR

T1 - G2019s-LRRK2 expression augments α-synuclein sequestration into inclusions in neurons

AU - Volpicelli-Daley, Laura A.

AU - Abdelmotilib, Hisham

AU - Liu, Zhiyong

AU - Stoyka, Lindsay

AU - Daher, João Paulo Lima

AU - Milnerwood, Austen J.

AU - Unni, Vivek

AU - Hirst, Warren D.

AU - Yue, Zhenyu

AU - Zhao, Hien T.

AU - Fraser, Kyle

AU - Kennedy, Richard E.

AU - West, Andrew B.

PY - 2016/7/13

Y1 - 2016/7/13

N2 - Pathologic inclusions define α-synucleinopathies that include Parkinson’s disease (PD). The most common genetic cause of PD is the G2019S LRRK2 mutation that upregulates LRRK2 kinase activity. However, the interaction between α -synuclein, LRRK2, and the formation of α -synuclein inclusions remains unclear. Here, we show that G2019S-LRRK2 expression, in both cultured neurons and dopaminergic neurons in the rat substantia nigra pars compact, increases the recruitment of endogenous α -synuclein into inclusions in response to α -synuclein fibril exposure. This results from the expression of mutant G2019S-LRRK2, as overexpression ofWT-LRRK2not only does not increase formation of inclusions but reduces their abundance. In addition, treatment of primary mouse neurons with LRRK2 kinase inhibitors, PF-06447475 and MLi-2, blocks G2019S-LRRK2 effects, suggesting that the G2019S-LRRK2 potentiation of inclusion formation depends on its kinase activity. Overexpression of G2019S-LRRK2 slightly increases, whereas WT-LRRK2 decreases, total levels of α -synuclein. Knockdown of total α -synuclein with potent antisense oligonucleotides substantially reduces inclusion formation in G2019S-LRRK2-expressing neurons, suggesting that LRRK2 influences α -synuclein inclusion formation by altering α -synuclein levels. These findings support the hypothesis that G2019S-LRRK2 may increase the progression of pathological α -synuclein inclusions after the initial formation of α -synuclein pathology by increasing a pool of α -synuclein that is more susceptible to forming inclusions.

AB - Pathologic inclusions define α-synucleinopathies that include Parkinson’s disease (PD). The most common genetic cause of PD is the G2019S LRRK2 mutation that upregulates LRRK2 kinase activity. However, the interaction between α -synuclein, LRRK2, and the formation of α -synuclein inclusions remains unclear. Here, we show that G2019S-LRRK2 expression, in both cultured neurons and dopaminergic neurons in the rat substantia nigra pars compact, increases the recruitment of endogenous α -synuclein into inclusions in response to α -synuclein fibril exposure. This results from the expression of mutant G2019S-LRRK2, as overexpression ofWT-LRRK2not only does not increase formation of inclusions but reduces their abundance. In addition, treatment of primary mouse neurons with LRRK2 kinase inhibitors, PF-06447475 and MLi-2, blocks G2019S-LRRK2 effects, suggesting that the G2019S-LRRK2 potentiation of inclusion formation depends on its kinase activity. Overexpression of G2019S-LRRK2 slightly increases, whereas WT-LRRK2 decreases, total levels of α -synuclein. Knockdown of total α -synuclein with potent antisense oligonucleotides substantially reduces inclusion formation in G2019S-LRRK2-expressing neurons, suggesting that LRRK2 influences α -synuclein inclusion formation by altering α -synuclein levels. These findings support the hypothesis that G2019S-LRRK2 may increase the progression of pathological α -synuclein inclusions after the initial formation of α -synuclein pathology by increasing a pool of α -synuclein that is more susceptible to forming inclusions.

KW - Lewy body

KW - Lewy neurite

KW - LRRK2

KW - Parkinson’s

KW - Synuclein

UR - http://www.scopus.com/inward/record.url?scp=84978841976&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978841976&partnerID=8YFLogxK

U2 - 10.1523/JNEUROSCI.3642-15.2016

DO - 10.1523/JNEUROSCI.3642-15.2016

M3 - Article

VL - 36

SP - 7415

EP - 7427

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 28

ER -